Skip to Content
 

News: Home Page Feature

VICC, Tempus launch new data initiative to help cancer patients

Thursday, January 18th, 2018

Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Vanderbilt-Ingram Cancer Center (VICC) have announced a new collaboration to improve outcomes for cancer patients.

Lung screening program continues to grow

Thursday, January 11th, 2018

Vanderbilt University Medical Center’s (VUMC) Lung Screening Program for patients at high risk for cancer recently reached a milestone, enrolling more than 700 patients and performing more than 1,000 CT screening examinations.

Rathmell elected to ASCO nominating committee

Tuesday, December 19th, 2017

W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee of the American Society of Clinical Oncology (ASCO).

Catching the nation’s deadliest cancer; how lung screening can help

Monday, November 27th, 2017

Lung screening improves odds for lung cancer survival. Learn who should be screened.

Smoking study personalizes treatment

Thursday, November 16th, 2017

A simple blood test is allowing Vanderbilt University Medical Center (VUMC) researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.

Vanderbilt joins national neurofibromatosis network

Thursday, November 9th, 2017

The Vanderbilt-Ingram Cancer Center Neurofibromatosis (NF) Clinic has joined the Children’s Tumor Foundation NF Clinic Network. The network consists of 50 clinics dedicated to improving care and advancing research for people diagnosed with NF, a group of diseases that is often inherited and cause benign tumors to grow on nerves throughout the body.

Lung cancer survivors and caregivers invited to VUMC event Nov. 16

Monday, November 6th, 2017

Lung cancer survivors and their caregivers are invited to attend a free educational evening at Vanderbilt University Medical Center (VUMC) Thursday, Nov. 16, 5:30 – 8:30 p.m., at the University Club, 2402 Garland Ave.

Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR T therapy

Wednesday, October 25th, 2017

Vanderbilt-Ingram Cancer Center (VICC) has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients with a specific type of lymphoma.

Symposium honors Moses’ storied cancer research career

Friday, October 20th, 2017

Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D., Career Development Fund.

It’s all about the patient for surgical oncologist Solorzano

Friday, October 6th, 2017

Surgical oncologist Carmen Solórzano, M.D., senses she has a reputation for being tough on residents. It doesn’t bother her.

You don’t get to be a professor of Surgery, chief of the Division of Surgical Oncology, and Director of the Vanderbilt Endocrine Surgery Center without setting exacting standards, both for yourself and those who work with you.

Next Page »